iCell Gene Therapeutics

iCell Gene Therapeutics

Biotechnology

Stony Brook, New York 1,087 followers

About us

iCell Gene Therapeutics is a clinical-stage biopharmaceutical company developing chimeric antigen receptor (CAR) immunotherapies designed to be innovative, first-in-class and lifesaving. We are focused on developing treatments for diseases where no treatment options exist and where dramatic increases in quality and duration of life are needed, including autoimmune disorders, AML, and T-cell malignancies. We are currently conducting clinical trials in the U.S. and China utilizing our CARvac, T-cell targeted CARs, compound CARs and non-gene edited universal CARs engineered as treatments for autoimmune diseases, cancer, and organ rejections. For more information, please visit http://icellgene.com/

Website
http://icellgene.com/index.html
Industry
Biotechnology
Company size
11-50 employees
Headquarters
Stony Brook, New York
Type
Privately Held
Founded
2014

Locations

Employees at iCell Gene Therapeutics

Updates

Similar pages

Browse jobs